Objective: Pretransfusion ABO compatibility testing is a simple and required precaution against ABO-incompatible transfusion, which is one of the greatest threats in transfusion medicine. While distinct agglutination is most important for correct test interpretation, protection against infectious diseases and ease of handling are crucial for accurate test performance. Therefore, the aim of this study was to evaluate differences in test card design, handling, and user safety. Design: Four different bedside test cards with pre-applied antibodies were evaluated by 100 medical students using packed red blood cells of different ABO blood groups. Criteria of evaluation were: agglutination, labelling, handling, and safety regarding possible user injuries. Criteria were rated subjectively according to German school notes ranging from 1 = very good to 6 = very bad/insufficient. Results: Overall, all cards received very good/good marks. The ABO blood group was identified correctly in all cases. Three cards (no. 1, no. 3, no. 4) received statistically significant (p < 0.008) prominence (mean values shown) concerning clearness of agglutination (1.7-1.9 vs. 2.4 for no. 2). Systems with dried antibodies (no. 2, no. 4) outmatched the other systems with respect to overall test system performance (2.0 vs. 2.8-2.9), labelling (1.5 vs. 2.2-2.4), handling (1.9-2.0 vs. 2.5), and user safety (2.5 vs. 3.4). Analysis of card self-explanation revealed no remarkable differences. Conclusion: Despite good performance of all card systems tested, the best results when including all criteria evaluated were obtained with card no. 4 (particularly concerning clear agglutination), followed by cards no. 2, no. 1, and no. 3. 
Introduction
Non-infectious hazards such as incidents of erroneous ABO mismatches are now the main risks associated with blood transfusion [1] . The bedside performance of the ABO compatibility test is considered as the ultimate blood safety wall as ABO-incompatible blood transfusion can reliably be prevented [2] [3] [4] [5] . Therefore, it is a legal requirement in many European countries [3, 4, 6] . Reluctant testing may result in inaccurate performance causing ABO mismatch [7] [8] [9] and the risk of lethal transfusion reactions [10] [11] [12] . Errors can be due to device failures, poor technique, and incorrect interpretation. Among 161 retrospectively evaluable cases of ABO mismatch reported in a French hemovigilance study between 1991 and 1998 [13] , the mandatory bedside test was not performed at all in one third of cases. In a further third of cases, problems of location (test not done at the bedside), time (test done some time before/after the transfusion) or identity (incorrect blood transfused) were detected. The final third of errors was related to incorrect techniques resulting in incorrect interpretation. Additionally, if bedside testing had been performed correctly in each case, 7 of 8 ABO-incompatible transfusions diagnosed at the Charité University Hospital in Berlin, Germany, between January 1997 and December 2004 would have been prevented [14] . As a consequence this test needs, apart from valid results, easy conduction and design to ensure accurate performance and correct use being crucially important for correct test interpretation [15, 16] . Despite this, comparative data of different bedside techniques due to different card designs (e.g. dried antibodies vs. liquid antibodies [17, 18] ), is scarce [8, 19] .
While some investigators evaluated the influence of user experience and training on test reliability [20, 21] , no studies have yet been published that investigate the impact of card design on performance and interpretation facility. In this study, four different bedside test systems with widespread use in the European community were evaluated by hardly experienced users with respect to agglutination/interpretation, ease of handling, and user convenience.
Material and Methods
All commercially available bedside compatibility test systems with pre-applied antibodies (bedside cards) used in this study are specified in table 1. Dried colored antibodies were mounted on the surface of cards no. 2 and no. 4 and had to be dissolved with a suspension of saline and red blood cells of the blood to be tested (card type I). Cards no. 1 and no. 3 contained antibody solutions in small pits covered by a plastic film where the blood sample had to be injected through before testing (card type II). Test systems were evaluated by 100 medical students in the beginning of their clinical training. All students were provided with general working instructions on a working sheet, specific instructions on the cards or their wrappings (except for card no. 3 offering one instruction per 20 cards only), evaluation sheets, syringes, cannulas, and mixing-sticks. During the first 15 min, the students were informed about bedside testing and the study's aim. They were then invited to familiarize themselves with the devices and ask questions concerning the overall performance. Each student was then given a questionnaire and a blood sample prior harvested from packed red blood cells by the investigator. Points of questionnaire were: distinct/clear agglutination, self explanation of the system examined, unambiguous labelling, ease of handling, simplicity of use of the overall test system, and user safety. Results were rated subjectively using German school notes (1 = very good, 2 = good, 3 = satisfactory, 4 = sufficient, 5 = unsatisfactory, 6 = very bad/insufficient). 
Discussion
ABO incompatibility still represents one of the most threatening risks in transfusion medicine [7] . It is most often the result of human error [9] associated with a failure in organization [13] . Bedside testing performed immediately prior to transfusion can prevent this complication [4] and is therefore required by law in many countries. The critical issue in bedside testing for ABO compatibility is the accuracy of the test and its interpretation, depending markedly on correct use of the device [15, 16] . As could be shown recently, high rates of erroneous transfusion decisions were due to defective techniques and poor user performance [14, 16] . Some reports have been published to introduce new bedside test cards [17] [18] [19] 23 ], but only a few studies compared different card systems [6, 19] . So far, no publications focused on differences in card design, which could influence clearness of agglutination, handling, labelling, self-explanation and putative user safety, being of utmost importance for integration into clinical routine as well as correct test performance and interpretation. The ABO compatibility test is a laboratory test, and physicians or nurses are clearly not laboratory technicians. Thus, it is essential that users not involved in laboratory transfusion medicine performed the assessment of the test cards. We therefore recruited 100 medical students in the medical training status. Lack of transfusion experience was considered important as experience with a given test system/product may provoke a bias towards the known type. Furthermore, the risk of erroneous detection of agglutination is reported to decrease with increasing transfusion experience [16, 20, 21, 24] although inexperienced users must also be sure of their test results. Overall, all cards received good marks and matched the given ABO blood group correctly. Therefore, statistically significant prominence observed for cards no. 1, no. 3, and no. 4 over card no. 2 concerning clearness of agglutination and for card type I (dried antibodies) concerning putative user safety relative to systems with film-covered liquid reagents (type II) must not automatically be of clinical relevance. However, especially an unambiguous and clear agglutination, best rated for card no. 4, is crucial for correct test interpretation [19, 20] . All features that facilitate the procedure and improve the detection of agglutination may reduce the risk of error [16] , particularly in inexperienced investigators. Therefore, the inferiority of card no. 2 seems remarkable, especially when compared to card no. 4, representing the same type with dried antibodies. Dilution with saline solution is known to simplify test interpretation and was described on the working instruction sheets, but Even in the absence of working instructions, self-explanation was rated the same for all cards. Similarity between test systems appears to cover up application uncertainties.
In conclusion, all cards tested showed good results. Therefore, all four bedside cards can be recommended for clinical routine. Nevertheless, our study revealed significant differences regarding clear test interpretation and user safety. Systems with dried antibodies were regarded safer than systems with antibodies in liquid form. Only one card (no. 4) combined both good agglutination and user safety. Mathematically, the best results were obtained for card no. 4, followed by cards no. 2, no. 1, and no. 3. Correct test interpretation also by users with little transfusion experience depends on correct use of the device which is facilitated by an easy and convenient test design, and the results of our study may help to lower the risk of misinterpretation. Last but not least, the efforts to prevent incidents of ABO mismatches should not be concentrated solely to the bedside compatibility test but also should reinforce a positive culture of error all along the transfusion process. An increase in transfusion safety may require the introduction of further systems [14] , e.g. a tag on blood bags reminding staff to check a patient's wristband [25] .
